Cart (0 Items)
Your cart is currently empty.
View ProductsEvinacumab Biosimilar – Anti-ANGPTL3 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade |
|---|---|
| Source | CAS 1446419-85-7 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Evinacumab,REGN 1500,ANGPTL3,anti-ANGPTL3 |
| Reference | PX-TA1369 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Description of Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade
General information on Anti-ANGPTL3[Homo sapiens] (Evinacumab) Monoclonal Antibody
Evinacumab is a recombinant human IgG4 monoclonal antibody targeting human angiopoietin-like protein 3 (ANGPTL3). The ANGPTL protein family has many physiological functions-including the regulation of lipid metabolism. It has been noted that the loss-of-function mutation of ANGPTL3 leads to hypolipidemia and subsequently reduces cardiovascular risk, while increased function seems to be related to cardiovascular risk. Evinacumab has been used to treat homozygous familial hypercholesterolemia (HoFH). It has been sold under the Evkeeza brand name.
SDS-PAGE for Evinacumab Biosimilar - Anti-ANGPTL3 mAb
Evinacumab Biosimilar - Anti-ANGPTL3 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Antigen
Angiopoietin-related protein 3(Angptl3)
PX-P4758 210€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.